JP2020529845A5 - - Google Patents

Download PDF

Info

Publication number
JP2020529845A5
JP2020529845A5 JP2020505248A JP2020505248A JP2020529845A5 JP 2020529845 A5 JP2020529845 A5 JP 2020529845A5 JP 2020505248 A JP2020505248 A JP 2020505248A JP 2020505248 A JP2020505248 A JP 2020505248A JP 2020529845 A5 JP2020529845 A5 JP 2020529845A5
Authority
JP
Japan
Prior art keywords
polypeptide
pharmaceutical composition
wnt3a
seq
wnt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020505248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020529845A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/044886 external-priority patent/WO2019028186A1/en
Publication of JP2020529845A publication Critical patent/JP2020529845A/ja
Publication of JP2020529845A5 publication Critical patent/JP2020529845A5/ja
Priority to JP2024075397A priority Critical patent/JP2024120178A/ja
Pending legal-status Critical Current

Links

JP2020505248A 2017-08-01 2018-08-01 Ｗｎｔ組成物および無血清培養条件からの処理の方法 Pending JP2020529845A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075397A JP2024120178A (ja) 2017-08-01 2024-05-07 Ｗｎｔ組成物および無血清培養条件からの処理の方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762539960P 2017-08-01 2017-08-01
US62/539,960 2017-08-01
US201862630448P 2018-02-14 2018-02-14
US62/630,448 2018-02-14
PCT/US2018/044886 WO2019028186A1 (en) 2017-08-01 2018-08-01 WNT COMPOSITIONS AND METHODS OF TREATMENT FROM SERUM-FREE CULTURE CONDITIONS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075397A Division JP2024120178A (ja) 2017-08-01 2024-05-07 Ｗｎｔ組成物および無血清培養条件からの処理の方法

Publications (2)

Publication Number Publication Date
JP2020529845A JP2020529845A (ja) 2020-10-15
JP2020529845A5 true JP2020529845A5 (https=) 2021-09-09

Family

ID=65234165

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020505248A Pending JP2020529845A (ja) 2017-08-01 2018-08-01 Ｗｎｔ組成物および無血清培養条件からの処理の方法
JP2024075397A Pending JP2024120178A (ja) 2017-08-01 2024-05-07 Ｗｎｔ組成物および無血清培養条件からの処理の方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075397A Pending JP2024120178A (ja) 2017-08-01 2024-05-07 Ｗｎｔ組成物および無血清培養条件からの処理の方法

Country Status (8)

Country Link
US (1) US20200399588A1 (https=)
EP (1) EP3661475A4 (https=)
JP (2) JP2020529845A (https=)
CN (1) CN111182880B (https=)
AU (1) AU2018309026A1 (https=)
CA (1) CA3071638A1 (https=)
GB (2) GB2610090B (https=)
WO (1) WO2019028186A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3728287T3 (da) * 2017-12-19 2024-06-10 CSL Behring Lengnau AG Proteinoprensning og virusinaktivering med alkylglycosider
CN115702242A (zh) * 2020-04-20 2023-02-14 医药控股公司 一种改性的细菌透明质酸酶多肽、生产方法、药物组合物及其用途
CN116359367B (zh) * 2022-12-27 2023-08-25 绍兴市食品药品检验研究院 一种同位素内标高效液相色谱串联质谱法检测食品中γ-氨基丁酸的方法
US20260023050A1 (en) * 2024-07-22 2026-01-22 Waters Technologies Corporation Methods for analyzing lipid nanoparticles and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479535B2 (ja) * 1993-07-08 2003-12-15 ザ リポソーム カンパニー、インコーポレーテッド リポソームの粒径を制御する方法
US6610316B2 (en) * 1997-05-30 2003-08-26 Shanbrom Technologies, Llc Disinfection by particle-bound and insolubilized detergents
WO2006036175A2 (en) * 2004-09-21 2006-04-06 Rhode Island Hospital, A Lifespan-Partner Wnt proteins and detection and treatment of cancer
US20070072239A1 (en) * 2005-09-26 2007-03-29 Wyeth Pharmaceutical compositions and methods of using secreted frizzled related protein
DK2585098T3 (da) * 2010-06-28 2014-11-03 Five Prime Therapeutics Inc Ekstracellulære FZD8-domæner og fusionsmolekyler fraekstracellulære FZD8-domæner til anvendelse ved behandling afobesitet og obesitet-relaterede lidelser
JP2014527818A (ja) * 2011-09-16 2014-10-23 フェイト セラピューティクス，インコーポレイテッド Ｗｎｔ組成物およびそのような組成物の治療的使用
AU2013334790A1 (en) * 2012-10-23 2015-04-30 Oncomed Pharmaceuticals, Inc. Methods of treating neuroendocrine tumors using Wnt pathway-binding agents
MX372810B (es) * 2013-10-02 2020-07-03 Univ Leland Stanford Junior Composiciones de wnt y metodos para purificacion.
WO2017132494A1 (en) * 2016-01-28 2017-08-03 The Board Of Trustees Of The Leland Stanford Junior University Wnt compositions and methods for serum-free synthesis

Similar Documents

Publication Publication Date Title
JP2020529845A5 (https=)
JP6348946B2 (ja) 延長組換えポリペプチドおよび延長組換えポリペプチドを含む組成物
JP5209463B2 (ja) アシル化ｇｌｐ−１化合物
JP6519929B2 (ja) Ｇｌｐ−１類似体融合タンパク質とその作製方法及び用途
JP2008533106A (ja) 伸長されたｇｌｐ−１化合物
ATE169959T1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
JP2015057058A (ja) 組織傷害の修復におけるストロマ細胞由来因子１のプロテアーゼ耐性変異体
FI3510049T3 (fi) Happo alfa-glukosidaasin muunnoksia ja niiden käyttöjä
KR20160138133A (ko) 안정화된 피브로넥틴 기반 스캐폴드 분자
JP2024120178A (ja) Ｗｎｔ組成物および無血清培養条件からの処理の方法
FI4034555T3 (fi) Dap10/dap12-fuusiopolypeptidit
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
CN102311501A (zh) 含有glp-1或其类似物的融合蛋白、制备方法及其应用
JP2004505601A5 (https=)
US20210253655A1 (en) Polypeptides, nucleic acid molecules, compositions, and related methods
JP2009519296A (ja) ポリペプチド延長タグ
US6337194B1 (en) Method for the preparation of insulin by cleavage of a fusion protein and fusion proteins containing insulin A and B chains
Käkönen et al. Purification and characterization of recombinant osteocalcin fusion protein expressed inEscherichia coli
JP5877988B2 (ja) 蛍光タンパク質を用いた分子認識センサー、分子放出複合体及びその合成
US11034946B2 (en) Glycosylation independent proteins
CA2247998C (en) Fragments of cr1 and their use
KR20200113764A (ko) 폴리글루타메이트-TAT-Cre 융합 단백질의 제조방법
US20110306125A1 (en) Protein Expression Methods
Langoscha et al. Lehrstuhl Chemie der Biopolymere, Technische Universität München, Weihenstephaner Berg 3, 85354 Freising (Germany), Fax:+ 49-8161-714404, e-mail: langosch@ lrz. tum. de b University of Osnabrück, Department of Biology, Biochemistry, Barbarastrasse 13, 49076 Osnabrück (Germany)